Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

January 01, 2007 (Vol. 27, No. 1)

Therapeutic Cancer Vaccine Options

VC Hesitation Is Largely Unfounded

  • Safety and quality of life are becoming more important to patients, and because of this the field of therapeutic cancer vaccines should be moving a lot faster than it is, said Jean-Yves Bonnefoy, Ph.D., vp R&D, Transgene (www.transgene.fr) at the recent “World Vaccine Congress” in Lyon, France. Therapeutic ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.